Navigation Links
CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
Date:11/27/2012

WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- At today's National Prescription Drug Abuse Prevention Policy Consensus Meeting, the not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) announced the results of its national contest to identify the "Top 5 Technologies To Reduce Prescription Drug Abuse." 

In alphabetical order, the Top 5 honorees are …

  • Atlantic Pharmaceuticals' SMART/Script dosage form to decrease medication tampering;
  • Eagle Advancement Institute's Clarity program for opioid detoxification, addiction treatment, and aftercare;
  • Egalet's erosion-based drug delivery platform, designed to resist tampering;
  • The Locking Cap, a combination bottle cap to prevent unauthorized access to prescription medications, particularly by children and teens; and
  • Pisgah Labs' P2P Interventions process, designed to safeguard medications' active ingredients.

Honorable mention goes to Abuse Tech's Abuse-Loc, a locking medication bottle to prevent the diversion of drugs from homes.

The Top 5 Technologies competition aims to increase public awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.

Michael Barnes, spokesman for CLAAD, stated, "These companies have demonstrated a sincere commitment to reducing prescription drug abuse. We hope the Top 5 Technologies recognition will expedite their success in meeting that goal."

San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest. Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.

"We are proud to recognize the Top 5 honorees joining Millennium in the critically important effort to advance patient care and help address the epidemic of prescription drug abuse," said Howard Appel, President of Millennium Laboratories. 

About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is the sponsor of the National Prescription Drug Abuse Prevention Policy Consensus meeting.  In its fifth year, the annual event brings together representatives of government, non-profit health and safety organizations, and industry to identify how best to reduce prescription drug abuse while optimizing patient care.  Follow @claad_coalition.

About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety. 


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CLAAD Warns of Increase in Prescription Drug Overdoses
2. CLAAD Names Eagle Advancement Institute as Honoree of Top 5 Technologies To Reduce Prescription Drug Abuse
3. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
4. Isis Reports Financial Results and Highlights for First Quarter 2012
5. Delcath Highlights First Quarter 2012 And Recent Accomplishments
6. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
7. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
8. PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
9. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
10. The Galien Foundation Announces Roster of Luminary Presenters for Third Galien Forum; Program Highlights Include CEO Panel, Panel on Alzheimers Disease Innovation, Nobel Laureate Elie Wiesel
11. Cardinal Health Highlights Independent Pharmacy Best Practices At Retail Business Conference 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... Massachusetts , July 25, 2017 The med-tech ... rare nervous system diseases, has concluded a worldwide license agreement ... drug SOM0226 against transthyretin amyloidosis (ATTR). Before this licensing agreement ... a Phase 2 study conducted in Europe ... the United States ...
(Date:7/24/2017)... July 24, 2017 IBM (NYSE: IBM ) ... Quadrant for Solid-State Arrays (SSA) for the fourth year in ... According to Gartner, "Vendors in the Leaders quadrant have the ... Vision. A vendor in the Leaders quadrant has the market ... the acceptance of new technologies. These vendors demonstrate a clear ...
(Date:7/21/2017)... and EDMONTON, Alberta , ... scientists and the University of Alberta in ... data in Nature,s partner journal, Schizophrenia 1 , ... predict instances of schizophrenia with 74% accuracy. This ... severity of specific symptoms in schizophrenia patients with ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Fusion Flix Inc., a Telly ... over four countries and millions of viewers in a partnership with the Amazon Video ... On-Demand and fully available on Blu Ray disc in 2018. Proceeds will be going ...
(Date:8/16/2017)... ... 2017 , ... Richard Strawn’s new book Surgical Psalms ... a cancer diagnosis, surgery and recovery, the Psalms provided encouragement and hope, as ... shows love to those who are sick., Surgical Psalms contains 36 reflections about ...
(Date:8/16/2017)... ... , ... TopConsumerReviews.com recently gave a best-in-class 5 star rating to Test Country, ... the United States has undergone major changes over the last decade, particularly when it ... order to get a blood test or other lab work done. Today, most tests ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... opportunity for men and women to train as hospice volunteers. Volunteers provide much ... illness. For over 30 years, the agency has trained volunteers to be vital ...
(Date:8/16/2017)... ... 2017 , ... First Choice Emergency Room , the largest network of ... the new Medical Director of its Sienna Plantation facility. , “We are pleased ... Plantation location,” said Dr. Michael (Derek) Caraway, Area Medical Director of First Choice Emergency ...
Breaking Medicine News(10 mins):